Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective.
Gary X WangTravis P BaggettPari V PandharipandeElyse R ParkSanja Percac-LimaJo-Anne O ShepardFlorian J FintelmannEfrén J FloresPublished in: Radiology (2019)
Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer screening (LCS) with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. Patients and referring providers confront numerous barriers to participation in screening. To best serve in multidisciplinary efforts to expand LCS nationwide, radiologists must be knowledgeable of these challenges. A better understanding of the difficulties confronted by other stakeholders will help radiologists continue to collaboratively guide the growth of LCS programs in their communities. This article reviews barriers to participation in LCS for patients and referring providers, as well as possible solutions and interventions currently underway.
Keyphrases
- end stage renal disease
- low dose
- ejection fraction
- chronic kidney disease
- physical activity
- newly diagnosed
- peritoneal dialysis
- healthcare
- type diabetes
- randomized controlled trial
- social media
- artificial intelligence
- magnetic resonance imaging
- emergency department
- machine learning
- cardiovascular events
- cardiovascular disease
- mental health
- systematic review
- patient reported outcomes
- magnetic resonance
- health insurance
- squamous cell
- case report
- papillary thyroid
- deep learning
- meta analyses
- pet ct
- dual energy
- childhood cancer